MADSION, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Dr. Fred Robertson, CEO, and Steve Hathaway, CFO, will present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 6, at 1:40 p.m., ET. The conference is scheduled February 5-7 at the Grand Hyatt Hotel in New York City.
